You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 76282-0214


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 76282-0214

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
SERTRALINE HCL 100MG TAB Exelan Pharmaceuticals, Inc. 76282-0214-01 100 8.86 0.08860 2020-09-15 - 2025-09-14 FSS
SERTRALINE HCL 100MG TAB Exelan Pharmaceuticals, Inc. 76282-0214-05 500 39.26 0.07852 2021-02-04 - 2025-09-14 FSS
SERTRALINE HCL 100MG TAB Exelan Pharmaceuticals, Inc. 76282-0214-30 30 4.73 0.15767 2021-02-04 - 2025-09-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

76282-0214 Market Analysis and Financial Projection

Market Analysis and Price Projections for Sertraline (NDC: 76282-0214)

Overview of Sertraline

Sertraline, marketed under various brand names, is a selective serotonin reuptake inhibitor (SSRI) used to treat a range of mental health conditions, including major depressive disorder (MDD), obsessive-compulsive disorder (OCD), panic disorder (PD), post-traumatic stress disorder (PTSD), social anxiety disorder (SAD), and premenstrual dysphoric disorder (PMDD)[1].

Current Market Pricing

As of the latest data, the prices for sertraline hydrochloride tablets, specifically those with the NDC code 76282-0214, vary slightly depending on the package size and vendor.

  • For a 100 mg tablet, the price per unit is approximately $0.04138[4].

Price Trends and Projections

Recent Pricing Data

The current pricing for sertraline tablets indicates a stable market price. For example, the price per unit for a 100 mg tablet from Exelan Pharmaceuticals, Inc. has been consistent at $0.04138 across different package sizes[4].

Impact of Medicare Price Negotiation

While sertraline itself is not listed among the first set of drugs selected for Medicare price negotiation, the broader trend of price negotiations under the Medicare program could have indirect effects on the pricing of other medications. The Biden-Harris Administration's efforts to negotiate lower prices for certain drugs under Medicare could set a precedent and potentially influence pricing strategies across the pharmaceutical industry[5].

Pharmaceutical Industry Trends

In 2024, the pharmaceutical industry is expected to see several trends that could influence drug pricing:

  • Outsourcing and Contract Manufacturing: The growth in outsourcing drug development and manufacturing to Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) could lead to cost reductions and improved efficiency, potentially stabilizing or reducing drug prices[3].
  • Personalized Medicine: The increasing focus on personalized medicine, driven by advancements in AI and data analysis, might lead to more targeted and effective treatments, but it could also introduce new cost dynamics[3].
  • Emerging Markets: The growth in emerging markets, driven by large populations and increasing healthcare demand, could expand the market for sertraline and other drugs, potentially affecting pricing due to increased demand[3].

Regulatory and Market Dynamics

Regulatory Environment

The regulatory climate, including initiatives like the Medicare price negotiation program, is likely to play a significant role in shaping drug prices. While sertraline is not currently part of this program, future expansions or similar initiatives could impact its pricing[5].

Competition and Generic Market

Sertraline is available in generic form, which generally keeps prices lower compared to brand-name drugs. The presence of multiple generic manufacturers contributes to a competitive market, helping to maintain stable or lower prices[4].

Key Takeaways

  • Current Pricing: The current price per unit for sertraline 100 mg tablets is around $0.04138.
  • Market Trends: Outsourcing, personalized medicine, and growth in emerging markets are expected to influence the pharmaceutical industry, potentially stabilizing or reducing drug prices.
  • Regulatory Impact: Medicare price negotiation programs and other regulatory initiatives could indirectly affect the pricing of sertraline by setting industry-wide pricing standards.
  • Generic Competition: The availability of generic sertraline helps maintain competitive pricing.

FAQs

  1. What is the current price per unit for sertraline 100 mg tablets with NDC 76282-0214?

    • The current price per unit is approximately $0.04138[4].
  2. How might the Medicare price negotiation program affect sertraline prices?

    • While sertraline is not currently part of the Medicare price negotiation program, the program's impact on other drugs could set a precedent and influence industry-wide pricing strategies[5].
  3. What are the key trends in the pharmaceutical industry that could affect sertraline pricing in 2024?

    • Trends include outsourcing of drug development, growth in personalized medicine, and increasing focus on emerging markets[3].
  4. Is sertraline available in generic form?

    • Yes, sertraline is available in generic form, which helps keep prices lower due to competition among generic manufacturers[4].
  5. How does the regulatory environment impact sertraline pricing?

    • The regulatory environment, including initiatives like the Medicare price negotiation program, can influence pricing by setting industry standards and promoting competitive pricing[5].

Sources

  1. DailyMed - Sertraline Tablet, Film Coated
  2. CMS - Medicare Drug Price Negotiation Program
  3. Global Pharma Tek - Top 12 Pharmaceutical Industry Trends in 2024
  4. DrugPatentWatch - Pharmaceutical drug prices and trends for SERTRALINE
  5. White House - Fact Sheet: Biden-Harris Administration Announces New, Lower Prices for First Ten Drugs Selected for Medicare Price Negotiation

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.